• Text size
  • Send this article to a friend
  • Print this article

ProStrakan to list on Nasdaq in two years

ProStrakan, the Borders-based specialist pharmaceutical group, yesterday said it was planning to list on the US Nasdaq stock exchange within two years as part of its assault on the lucrative North American market.

Custom byline text: 
MARK SMITH, Deputy Business Editor

ProStrakan, the Borders-based specialist pharmaceutical group, yesterday said it was planning to list on the US Nasdaq stock exchange within two years as part of its assault on the lucrative North American market.